Highlights of latest American College of Cardiology and American Heart Association Guidelines for Management of Patients with Acute Myocardial Infarction

Cardiology in Review

Volumn 10, Issue 1, 2002, Pages 35-43

  Ryan, Thomas J ^a   Melduni, Rowlens M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute myocardial infarction guidelines; Myocardial infarction treatment

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; MORPHINE;

ACUTE HEART INFARCTION; DRUG EFFICACY; DRUG USE; EMERGENCY WARD; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HUMAN; LONG TERM CARE; MEDICAL SOCIETY; MORTALITY; PRACTICE GUIDELINE; PUBLICATION; REVIEW; SURVIVAL; SYMPTOM; TIME;

EID: 0036161967     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045415-200201000-00008     Document Type: Review

References (25)

1. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
2. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
3. Causes of delay in seeking treatment for heart attack symptoms
4. Cardiopulmonary resuscitation research 1960-1984: Discoveries and advances
5. Use of the automatic external defibrillator in the management of out-of-hospital cardiac arrest
6. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
7. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB Trial: Thrombolysis in myocardial ischemia
8. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients
9. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2
10. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
11. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction
12. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomized trial
13. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction
14. Coronary stening stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction
15. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators: Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels
16. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
17. Age and outcome with contemporary thrombolytic therapy: Results from the GUSTO-I trial: Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries Trial
18. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease: Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group
19. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Unstable Angina)
20. Metoprolol in acute myocardial infarction Patient population
21. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators
22. Nifedipine: Dose-related increase in mortality in patients with coronary heart disease
23. Effects of prophylactic lidocaine in suspected acute myocardial infarction: An overview of results from the randomized, controlled trials
24. Prognosis in cardiogenic shock after acute myocardial infarcdon in the interventional era